Carl Von Ossietzky Universitaet Oldenburg
- Address
- lock Available on a paid plan
Infectious Diseases and Bacterial Infections
Research at Carl Von Ossietzky Universitaet Oldenburg includes infectious disease studies focused on serious bacterial infections, especially Staphylococcus aureus bacteremia. The trials are designed to assess how different treatment approaches may improve outcomes in patients with severe bloodstream infections.
- Evaluating treatment strategies for Staphylococcus aureus bacteremia
- Studying ways to reduce mortality in serious infection cases
- Supporting better therapeutic decision-making for bloodstream infections
This work reflects a strong interest in improving care for complex infections through comparative clinical research.
Hematology and Neoplasms
The site also conducts hematology and oncology research, with a focus on multiple myeloma and other neoplastic diseases. These studies aim to refine first-line treatment choices and better understand how to identify patients most likely to benefit from specific therapies.
- Investigating treatment effectiveness in multiple myeloma
- Assessing minimal residual disease as a marker of response
- Improving risk-adapted cancer care in blood cancers
This research supports more personalized approaches to cancer treatment and disease monitoring.
Perioperative Care and Therapeutics
Clinical trials in therapeutics and analytical, diagnostic and therapeutic techniques at this institution include studies in major abdominal surgery. The main goal is to evaluate whether treatment can reduce bleeding and lessen the need for blood transfusion during and after surgery.
- Studying tranexamic acid for surgical blood loss reduction
- Focusing on abdominal surgery outcomes
- Testing strategies to lower transfusion requirements
These trials are aimed at improving safety and recovery in patients undergoing complex operations.
Neurology and Cognitive Function
The research portfolio also extends to nervous system diseases, with studies examining neurological disorders and age-related changes in cognitive and motor function. The purpose is to explore whether enhancing brain signaling may improve everyday performance in older adults.
- Exploring interventions for neurological disorders
- Assessing cognitive-motor performance in older adults
- Testing approaches to support brain function and daily functioning
This area highlights interest in understanding how targeted treatments may affect thinking, movement, and overall brain activity.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 8 therapeutic areas and 15 of 30 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1University Of Cologne2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1University Of Cologne2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Carl Von Ossietzky Universitaet Oldenburg
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Early Switch to Oral Antibiotics Versus Standard Delayed Switch in Adults with Pyogenic Vertebral Osteomyelitis: A Multicenter Randomized Non‑Inferiority Trial (sWITCH‑VO) | University Of Cologne | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 30 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin | 2 | Unknown | 2023-10-26 | 2023-10-26 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.